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Porcine epidemic diarrhea virus (PEDV) causes lethal diarrhea in piglets that leads to great economic losses in East Asia. It was reported that
aminopeptidase N (APN) is the receptor for transmissible gastroenteritis virus (TGEV), human coronavirus 229E (HCoV-229E) and feline
coronavirus (FeCoV) which all belong to group I coronavirus including as well as PEDV. It was also confirmed previously that porcine
aminopeptidase N (pAPN) can bind to PEDV, and anti-pAPN antibodies may inhibit the combination. To investigate whether pAPN is a receptor
for PEDV, we transfected MDCK cells with porcine aminopeptidase (pAPN) cDNA and this enabled non-susceptible cells to support PEDV
replication and serial viral propagation. Moreover, the infection was blocked by antibodies against pAPN, implies the critical role of pAPN during
virus entry. In addition, immunofluorescence assays for detection of pAPN and PEDV antigens, together with neutralization assays using
antibodies against pAPN, further confirmed the correlation between pAPN expression and viral replication in pAPN-transfected MDCK cells.
These results indicate that pAPN is a functional receptor for PEDV.
© 2007 Elsevier Inc. All rights reserved.Keywords: Receptor; Porcine aminopeptidase; Porcine epidemic diarrhea virus; CoronavirusIntroduction
Porcine epidemic diarrhea virus (PEDV) is a member of the
Coronaviridae, causing severe entero-pathogenic diarrhea
especially in piglets. PEDV belongs to group I coronavirus
which consists of porcine epidemic diarrhea virus (PEDV),
transmissible gastroenteritis virus (TGEV), human coronavirus
229E (HCoV-229E), feline coronavirus (FeCoV), canine
coronavirus (CCV) and human coronavirus NL63 (NL or
New Haven) (Van der Hoek et al., 2004). Among them, TGEV,
HCoV-229E and FeCoV all use APN as their cellular receptor
(Delmas et al., 1992; Yeager et al., 1992; Tresnan et al., 1996;
Tresnan and Holmes, 1998; Kolb et al., 1998). It binds to spike
proteins of coronaviruses to mediate infection (Godet et al.,
1994; Bosch et al., 2003).
PEDV and TGEV induce rather similar clinical symptoms
which are hardly differentiated. Both of them replicate in the
differentiated enterocytes of the small intestine and cause severe
diarrhea (Sanchez et al., 1992). TGEV could be propagated in⁎ Corresponding author. Fax: +86 451 5510 3336.
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porcine kidney (PK-15) cells. However, the propagation of
PEDV had been unsuccessful until serial passage of the virus in
Vero cells (Hofmann and Wyler, 1988; Song et al., 2003). It is
known that porcine aminopeptidase N (pAPN) is a cellular
receptor for TGEV (Delmas et al., 1992, 1993; Hansen et al.,
1998; Schultze et al., 1995), pAPN is a 150-kDa glycosylated
transmembrane protein that is highly expressed in small
intestinal mucosa, where aminopeptidase represents about 8%
of the protein content of the apical membrane of the
differentiated enterocytes and catalyzes the removal of single
amino acids from the amino terminus of peptides for the final
steps of digestion (Delmas et al., 1992). It is a type II
glycoprotein, trypsin can cleave it into 2 subunits, N-terminal
part (95 kDa) and C-terminal part (50 kDa). The region between
residues 717 and 813 which contains the epitopes for three
neutralizing antibodies is essential for TGEV infection (Delmas
et al., 1994; Posthumus et al., 1990).
It was also demonstrated PEDV could bind to pAPN
specifically and this combination can be inhibited by anti-
pAPN antibodies (Oh et al., 2003). And soluble pAPN can
facilitate the production of PEDV in Vero cells, just as soluble
Fig. 1. Western blotting of the pAPN expressed in MDCK cells after
transfection. Lane 1, Native form of pAPN (Sigma) purified from porcine
kidney. Lane 2, MDCK cells transfected with pcDNA3.1–pAPN. Lane 3,
MDCK cells transfected with pcDNA3.1.
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(Werner et al., 1990; Schenten et al., 1999).
In this study, we transfected non-susceptible cell lines
Madin–Darby canine kidney (MDCK) cells for the transient
expression of pAPN and found this confers susceptibility to
PEDV and lead to serial passage. Then we further investigated
the ability of pAPN to mediate viral replication through
immunofluorescence and neutralization assays. The results
confirmed the correlation between pAPN expression and PEDV
production. All the data indicate that pAPN serves as a receptor
for PEDV that mediates virus entry and determines tissue
tropism.
Results
pAPN was expressed in MDCK cells through transfection
Proteins of transfected MDCK cells and native pAPN
(Sigma) were separated by SDS–gel electrophoresis and
electrotransferred onto a PVDF membrane for Western blotting.
Fig. 1 shows that anti-pAPN antibodies recognized wild-type
pAPN at 150 kDa, 95 kDa and 55 kDa, corresponding to
uncleaved pAPN (150 kDa), amino subunits (95 kDa) and
carboxy subunits (50 kDa) which were cleaved by trypsin. The
anti-pAPN antibodies also reacted with the protein of MDCK
cells transfected with pcDNA3.1–pAPN at 150 kDa, but not
with the cells transfected with pcDNA3.1, indicating that onlyFig. 2. pAPN protein expressed on plasma membrane were detected by indirect imm
secondary antibody. (A) pAPN-transfected MDCK cells. (B) MDCK cells. (C) ST cpcDNA3.1–pAPN conferred the expression of pAPN in MDCK
cells.
pAPN expressed at a high level in MDCK cells
To determine the expression level of pAPN on the plasma
membrane of MDCK cells compared with other cell lines,
expression of pAPN in MDCK cells was confirmed by
immunofluorescence by using polyclonal antibodies against
pAPN. Fig. 2 shows that pAPN expressed at a high level in
pAPN-transfected MDCK cells, strong fluorescence was
observed on cell membrane. While the mock-transfected
MDCK cells and Vero cells showed none green fluorescence,
indicates that pAPN is not present. As for ST cells, weaker
fluorescence was due to lower expression level of native pAPN
compared with pAPN-transfected MDCK cells.
Expression of pAPN in MDCK cells renders susceptibility to
PEDV
Based on the previous reports, we assumed that pAPN is a
cellular receptor for PEDV. To test this hypothesis, we isolated
total RNA from newborn piglet intestinal brush border
membrane which expresses pAPN at a high level, and amplified
pAPN gene. Then a recombinant plasmid expressing pAPN
with the eukaryotic expression vector pcDNA3.1 was con-
structed (named pcDNA3.1–pAPN). A newborn piglet was
orally infected in order to adapt the virus to grow to a high titer,
especially for the virus variants which potentially have stronger
replication ability in the transfected cells, and the virus was
purified subsequently. To determine PEDV replication, MDCK
cells which are not susceptible to PEDV were transfected for
transiently expression of pAPN on the plasma membrane. The
confluent monolayers were infected with the purified virus and
PEDV was passaged up to 5 times through transiently
transfected MDCK cells.
CPEs could be observed after about 36 h and the cell cultures
would completely lysed 48 h after inoculation. Figs. 3A, B and
C show that PEDV caused obvious CPEs in pAPN-expressing
MDCK cells at 24 and 36 h after infection, but not in MDCK
cells transfected with pcDNA3.1 alone at 36 h after inoculation.
At every passage, total cellular RNA was isolated and
subjected to nested RT–PCR for the detection of PEDV. As
shown in Fig. 4, PEDV was recovered after 5 successiveunofluorescence using pAPN-specific antibodies followed by FITC-conjugated
ells. (D) Vero cells.
Fig. 3. MDCK cells were transiently transfected with pcDNA3.1–pAPN or empty vector and then infected with PEDV, the cytopathic effects (CPEs) was observed. (A)
pAPN-transfected MDCK cells inoculated with PEDV were observed at 24 h after inoculation. (B) pcDNA3.1–pAPN was used to transfect MDCK cells followed by
PEDV inoculation, CPEs was examined at 36 h after infection. (C) MDCK cells were transfected with pcDNA3.1 and then infected with PEDV. The cells were
observed at 36 h after infection. pAPN-transfected MDCK cells were also infected with PEDV in the presence of anti-pAPN antiserum or a control antiserum. CPEs in
cells were examined at 36 h after inoculation. (D) Anti-pAPN antiserum was added to the maintenance medium. (E) A control antiserum was incubated with cells
throughout the infection.
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replication was not observed in the control cultures transfected
with pcDNA3.1, even after serial infections with frozen–
thawed cell monolayers, PEDV was not detectable by RT–PCR
after the first passage. Likewise, no CPEs was observed.
Detection of PEDV antigens by immunofluorescence assay
To confirm the proliferation of PEDV in pAPN-transfected
MDCK cells. After inoculation, the presence of PEDVantigens
in cells was examined by indirect immunofluorescence. Fig. 5
shows the expression of PEDV antigens in a pAPN-expressing
MDCK cells as detected by immunofluorescence with poly-
clonal antibodies. Proteins of PEDV were detectable in pAPN-
transfected cells. In contrast, extraordinary low level of fluo-
rescence was observed in pAPN-deficient MDCK cells.Fig. 4. Detection of PEDV RNA in virus suspension recovered from feces and
all virus cultures from passage 1 to 5 by nested RT–PCR assays. 412-bp PCR
fragments (sequence confirmed) could be observed. Lanes 1 and 2, PEDV of
virus suspension purified from feces and negative control. Lanes 3 to 12, 5 serial
passaged PEDV in pAPN-expressing MDCK cells and pAPN-deficient MDCK
cells as control groups.Infection of Vero cells with serially passaged PEDV
In order to confirm the critical role of pAPN expression
during the serial passage of virus, we investigate whether PEDV
virion could be recovered after 5 successive passages from
pAPN-expressing cells or empty vector-transfected cells,
supernatants at passage 5 were serially diluted and cytotoxicity
were determined on Vero cells as described. As shown in Fig. 6,
it was found that supernatant of pAPN-transfected MDCK cells
induced a significant loss of viability in Vero cell lines and the
cytotoxicity was reduced with the dilution of the supernatant.
Therefore, this confirmed the presence of virus. However, for
the Vero cells infected with supernatant collected from
pcDNA3.1-transfected MDCK cells, the loss of variability
was minimal and did not correlated with the dilution. Combined
with the results of electrophoresis, it was inferred that PEDV
could not proliferate because of the absence of pAPN.
Antibodies against pAPN inhibit PEDV infection
The ability of anti-pAPN antibodies to inhibit viral
replication on pAPN-transfected MDCK cells was then
investigated. Serial dilutions of anti-pAPN antiserum or a
control antiserum was preincubated with pAPN-expressing
MDCK cells for 1 h before infection, and the antibodies'
presence in the medium throughout the infection. Loss of cellFig. 5. MDCK cells transfected with pcDNA3.1–pAPN and MDCK cells were
infected with PEDV. 24 h post infection, immunofluorescence assays were
performed for the detection of PEDV antigens with anti-PEDV polyclonal
antibodies and FITC-conjugated secondary antibody. (A) pAPN-expressing
MDCK cells infected with PEDV. (B) MDCK cells infected with PEDV.
Fig. 6. Vero cells were infected with serially diluted supernatants collected from
PEDV-infected mock- and pAPN-transfected MDCK cells at serial passage 5.
Inoculation with the serially diluted supernatant of pAPN-transfected cells
corresponds to the decrease of cytotoxicity. However, infection with the serially
diluted supernatant of pcDNA3.1-transfected cells merely resulted in minimal
loss of viability without gradient change.
Fig. 7. pAPN-transfected MDCK cells were infected with PEDV in the presence
of serial dilutions of anti-pAPN antiserum or a control antiserum. Anti-pAPN
antibodies inhibited cytopathicity in a dose-dependent manner. In contrast, the
control antibody could not inhibit virus-induced cytopathicity.
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dose-dependent inhibition of cytopathic effect was observed in
the MDCK cells transfected with pcDNA3.1–pAPN in response
to the incubation with anti-pAPN polyclonal antibodies. With
the addition of anti-pAPN antiserum, cell monolayers deve-
loped relatively weak CPEs even at a dilution of 1:24. At the
same time, the control antibody showed no inhibition of the
infection of PEDV.
To further check the function of pAPN for infection, anti-
pAPN antiserum or a control antiserum at a dilution of 1:20 was
incubated with pAPN-expressing MDCK cells throughout the
infection. As shown in Figs. 3D and E, with the addition of anti-
pAPN antiserum, MDCK cells transfected with pcDNA3.1–
pAPN were shown to develop relatively weak CPEs at 36 h after
infection. At the same time, PEDV induced much stronger CPEs
to the cells incubated with control antibodies.
Discussion
To examine whether pAPN is a relevant receptor for PEDV,
MDCK cells transfected with pcDNA3.1–pAPN were exposed
to virus. Control groups were transfected with pcDNA3.1 alone.
PEDV can be experimentally adapted to pcDNA3.1–pAPN-
transfected cells. Viral RNA could be detected up to 5 serial
passages, and PEDV at serial passage 5 could infect Vero cells
as judged by the dose-dependent infection effect. As for the
control groups, the absence of pAPN results in the failure of
virus replication in MDCK cell culture, and PEDV's presence in
the cell culture. It is inferred that the expression of pAPN in
MDCK cells enabled serial propagation of PEDV.
To further confirm that virus entry into pAPN-transfected
MDCK cells via pAPN, western blot and immunofluorescence
assays were carried out to detect pAPN expression on the
plasma membrane of MDCK cells. pAPN expressed in MDCK
cells was a bit larger than native protein, it may be due to
glycolisation in MDCK cells. MDCK cell monolayers trans-
fected with pcDNA3.1–pAPN expressed pAPN at a signifi-
cantly high level compared with mock-transfected MDCK cells,ST cells and Vero cells (Delmas et al., 1992). This indicates that
there is a direct correlation between the efficiency of viral
replication and pAPN expression. In addition, the presence of
PEDV antigens in pAPN-expressing MDCK cells was proved
by indirect immunofluorescence. However, attempts to infect
pAPN-deficient MDCK cells with PEDV resulted in a rather
low level of antigen proteins as determined by immunofluor-
escence assays. Moreover, anti-pAPN antiserum could inhibit
CPEs significantly with a dose-dependent effect. From these
results, we deduce that high-level expression of pAPN
correlates with high-efficiency replication of PEDV, and the
susceptibility to PEDV was conferred by pAPN expression in
MDCK cells.
Generally, PEDV is adapted to serial propagation in Vero cell
cultures by adding trypsin but could not be propagated in ST
cell lines which are commonly used for TGEV propagation
(Hofmann and Wyler, 1988). The cellular receptor for TGEV in
STcells is pAPN which however can not render PEDV infection
(Delmas et al., 1992). And what mechanism causes such
discrimination?
One explanation may be that pAPN density plays a critical
role in PEDV infection. It is known that cellular receptor density
plays a critical role for the entry of some virus, such as oncolytic
measles virus and human immunodeficiency virus type 1
(Reynes et al., 2000; Anderson et al., 2004). As for natural
PEDV infection, porcine intestinal tissues are rather sensitive
and produce high-titer virus. In porcine intestinal brush border
membrane, pAPN is abundantly expressed and constitutes of
about 8% of the total membrane proteins. However, in ST cells,
as shown in Fig. 2, the expression level of pAPN is relatively
low. The expression level of pAPN may be an important factor
influencing PEDV entry. From our data, it can also be inferred
that the density of pAPN and PEDV infectivity might be
correlated, since high pAPN amount and enhanced replication
of PEDVoriginate from the same source. It is possible that in the
presence of trypsin, MDCK cells with high level of pAPN
expression are quite similar to intestinal villus membrane. Thus
we speculate that compared with TGEV, the infectivity of
PEDV maybe much more restricted by pAPN density.
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host range may be summarized as follows. This restriction could
be due to a defect in entry or a post-entry event. Other unknown
mechanisms might provide some supporting factors required for
virus entry and replication capacity. It remains to be determined
whether pAPN is sufficient for viral entry in some cell lines or a
secondary or earlier event is responsible for promoting entry. In
another word, it is likely that multiple receptor molecules
mediate PEDV infection or the replication is restricted at a post-
entry step, and it is also possible that the modification of PEDV
is needed. However, PEDV could infect Vero cells without
pAPN. It may be due to other receptors or receptor-independent
infection (Taguchi and Matsuyama, 2002).
From the results of our research and the previous reports, we
deduced that pAPN serves as a cellular receptor for PEDV.
However, the entire mechanism of PEDV entry is remained to
be unrevealed and further research is needed. Since MDCK
cells transiently expressing pAPN could be used for the
propagation of PEDV, it pointed out an alternative way to
construct an optimized cell line for the cultivation of PEDVand
providing adequate quantity of virus to meet the vaccine
requirements. Moreover, identifying the cellular receptor for




The MDCK-2 and Vero cells were cultured in growth
medium containing alpha minimum essential medium (Gibco)
supplemented with 8% FCS (Hyclone). Maintenance medium
consisted of alpha minimal essential medium supplemented
with 0.3% tryptose phosphate broth (Difco) and 0.02% yeast
extract (Oxoid) and 10 mg/ml trypsin (Sigma).
Virus
One local strain LJB/03 of PEDV was used for the
experiments (Jinghui and Yijing, 2005; Junwei et al., 2006).
A newborn piglet orally infected with PEDV fecal specimens
was sacrificed (Hofmann and Wyler, 1988). The content of the
small intestine were diluted 1:10 in PBS and homogenized
(Dounce homogenizer). The homogenate was centrifuged at
low-speed centrifugation (1000×g for 15 min at 4 °C), and
debris were pelleted by centrifugation (10,000×g for 15 min at
4 °C). The supernatants were concentrated by ultracentrifuga-
tion (150 ,000×g for 1 h at 4 °C). The pellet was resuspended up
in 1 ml maintenance medium and clarified by centrifugation
(10,000×g for 10 min at 4 °C). Then 1 ml 50% (w/v) filter-
sterilized sucrose was injected directly to the bottom of the tube
carefully without disturbing the pellet. Bacteria was then
removed through centrifugation (10000×g for 20 min at 4 °C)
by using of swinging bucket rotors. The resulting suspension
containing PEDV was aliquoted and stored at −80 °C. The
presence of PEDV was confirmed by RT–PCR with primer sets
used for diagnosis reported previously (Ishikawa et al., 1997;Kim et al., 2000; Kocherhans et al., 2001). The PCR fragment
was sequenced subsequently.
Antibodies
Polyclonal antibodies recognizing pAPN were prepared
from a BALB/c mice immunized with pAPN (Sigma) purified
from porcine kidney. Antiserum against PEDV was prepared
from a rabbit immunized with PEDV which was purified
from feces as described above.
Isolation of the porcine aminopeptidase cDNA
Total RNA was extracted from intestinal brush border
membrane of a newborn piglet using TRIzol Reagent (Invitrogen)
according to the manual. The porcine aminopeptidase coding
sequence was amplified by RT–PCR (Delmas et al., 1992; Olsen
et al., 1989). Primers used for the PCR were 5′ CTCC-
CTTCTCACCCTCACC3′ and 5′CCACAGGCTTTGTCCCTA
3′. The PCR product was subcloned into pMD18-T vector
(TaKaRa) followed by sequencing. The resulting plasmid was
named pMD-18T-pAPN. The full-length pAPN cDNA with
BamHI and HindIII restriction sites was PCR-amplified from
pMD-18T-pAPN, primers used for this step were 5′
TGGAAGCTTCTCCCTTCTCACCCT 3′ and 5′ CTGGGA-
TCCCCACAGGCTTTGTC 3′, sequences underlined are sites
for restriction enzymes. The PCR product was subsequently
subcloned into the corresponding restriction sites of pcDNA3.1
and sequenced to identify the orientation and integrity. The
constructed vector was named pcDNA3.1–pAPN. Plasmid
DNA was purified with a plasmid DNA purification kit
(Promega) for subsequent transfection.
Western blot analysis of the expression of pAPN
To determine the expression of pAPN in MDCK cells,
western blot analysis was performed. Freshly thawed MDCK
cells were seeded into a 24-well plate and cultured in growth
medium. Then the cells were grown overnight to 80–90%
confluency. In the presence of 8% FCS, transient transfection
was performed with 1.6 μg of pcDNA3.1–pAPN or pcDNA3.1
and 4 μl of Lipofectamine 2000 (Invitrogen) each well. 5 h later,
the transfection medium was replaced with fresh growth
medium.
36 h after transfection, cell monolayers were scrapped and
solubilized by boiling in SDS sample buffer. With pAPN protein
(Sigma) purified from porcine kidney as a positive control group,
the proteins were fractionated by SDS–polyacrylamide gel
electrophoresis, transferred to polyvinylidene difluoride (PVDF)
membrane, PVDF membrane was blocked for 2 h using 5% non-
fat milk in PBS and incubated for 1 h with a 1:100 dilution of the
mouse anti-pAPN antibodies. And 1:2000 dilution of horseradish
peroxidase-labeled goat anti-mouse IgGs were used as a
secondary antibody. Each of the incubations was performed at
37 °C followed by 3 times wash with phosphate-buffered saline
with 0.1% Tween 20 (PBST). Finally, the antibodies were
revealed with a 4-chloro-1-naphthol-based color development.
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Next we analyzed the expression level of pAPN in MDCK
cells. With ST and Vero cells as control groups, 24 h after
transfection of MDCK cells with plasmid-expressing pAPN or
pcDNA3.1 alone, the monolayers were washed with PBS and
fixed in 3% PFA at 4 °C for 15 min followed by 3 times wash
with PBS. Cells were then blocked with PBS containing 1%
BSA and incubated with a 1:50 dilution of mouse polyclonal
anti-pAPN antiserum. After 3 times wash with PBS–BSA,
the monolayer were stained by FITC-labeled goat anti-mouse
IgGs. The results were observed with a Zeiss fluorescence
microscope.
Serial passage of PEDV in pAPN-deficient and
pAPN-expressing MDCK cells
Viral inoculation of the cells was carried out 24 h after
transfection. The growth medium of the confluent cells was
removed and the monolayers were washed three times with
maintenance medium. The cell cultures were subsequently
inoculated with 0.3 ml per well of the clarified virus
suspension recovered from feces described above. After 1 h
of adsorption at 37 °C, without removing the viral inoculum,
1 ml of maintenance medium was transferred into each well.
Subsequently, the cells were incubated at 37 °C. Since trypsin
is thermolabile, 5 μl trypsin concentration (1 mg/ml) was
added to each well 24 h after inoculation. Infected cells were
harvested when the cells reached 70–80% CPEs. Then the
cultures were subjected to one freeze–thaw cycle and the
suspension was used for the next inoculation of pAPN-
expressing or control transfected MDCK cells. Serial passages
of PEDV were continued by level 5 according to the method
described above. PEDV was identified by nested RT–PCR for
each passage using the former primers, the PCR product of the
fifth passage of virus was sequenced.
Detection of viral antigens by immunofluorescence
For investigating the ability of pAPN-transfected MDCK
cells to support virus replication. Mock-transfected and pAPN-
transfected MDCK cells were inoculated with PEDV according
to the protocol described above. At 24 h post infection, the
monolayer were fixed by 3% PFA followed by permeabilization
using 0.2% Triton X-100. After blocking with PBS–BSA and
incubation with rabbit polyclonal anti-PEDV antibodies at a
1:100 dilution, they were then treated with FITC-labeled goat
anti-rabbit IgGs before examination under a fluorescence
microscope.
Infection of Vero cells with serially passaged PEDV
To identify the presence of virus after serial passage of
PEDV in pAPN-transfected MDCK cells. CytoTox 96
nonradioactive cytotoxicity assay (Promega) was performed
according to the manual of the manufacturer. Vero cells were
seeded into 96-well plates and grown for 24 h to achieve aconfluency of 80–90%, supernatants collected from PEDV
infected mock- and pAPN-transfected MDCK cells at serial
passage 5 were used to inoculate Vero cell at 1:1 dilution, 1:2
dilution, 1:4 dilution, 1:8 dilution, 1:16 dilution, 1:32 dilution,
1:64 dilution and 1:128 dilution in triplicate. Cytopathic effect
was then monitored for each well 36 h after infection.
Neutralization analysis using anti-pAPN antibodies
To ensure the critical role of pAPN during virus entry, we
examined whether anti-pAPN antiserum could inhibit PEDV
infection. Confluent monolayers of MDCK cells transiently
expressing pAPN in 96 plates were pretreated with 1:6 dilution,
1:12 dilution, 1:24 dilution, 1:48 dilution, 1:96 dilution, 1:192
dilution, 1:384 dilution and 1:768 dilution of polyclonal anti-
pAPN antibodies or a control antibody in medium for 1 h. And
cells were then infected with PEDVwith antibodies' presence in
the medium. After 36 h, virus-induced cytotoxicity was
measured at 490 nm using CytoTox 96 nonradioactive
cytotoxicity assay (Promega) according to the instruction of
the manufacturer. The experiment was performed in 3 replicate
wells for each antibody concentration.
Cytopathic effect was also observed to confirm the
neutralization effect of anti-pAPN antibodies. MDCK cells
transiently expressing pAPN were incubated with 20-fold
diluted polyclonal antibodies against pAPN or a control
antiserum 1 h prior to virus inoculation, and the antiserum
was present in the medium throughout the infection process.
CPEs were subsequently examined under a microscope.
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